Literature Review : Efek Suplementasi Kurkumin pada Penderita Diabetes Melitus
DOI:
https://doi.org/10.57213/antigen.v3i2.622Keywords:
Body Weight, Diabetes Mellitus, Glycemic Control, Kidney Function, Lipid ProfileAbstract
Diabetes mellitus is a condition of elevated blood glucose levels due to impaired insulin secretion, insulin resistance, or both. This disease can lead to various serious complications that impact quality of life if not properly managed. Current diabetes management generally involves dietary modification, physical activity, and antidiabetic drug therapy. However, recent research has revealed the potential of bioactive compounds from natural sources such as curcumin in minimizing the risk of diabetes-related complications. This literature review examines and analyzes research evidence on the effects of curcumin supplementation on health parameters in patients with diabetes mellitus. The review was conducted on English-language publications in the last 10 years (2014-2024) using electronic databases. The reviewed experimental and cohort studies demonstrate the influence and beneficial effects of curcumin on glycemic control, lipid profile, weight reduction, and kidney function protection in diabetic patients. Curcumin has the potential to contribute to reducing oxidative stress and inflammation as the main triggering factors for complications of diabetes mellitus.
References
Aggarwal, B. B., & Harikumar, K. B. (2009). Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. International Journal of Biochemistry and Cell Biology, 41(1), 40–59.
Al-Saud, N. B. S. (2020). Impact of curcumin treatment on diabetic albino rats. Saudi Journal of Biological Sciences, 27(2), 689–694.
American Diabetes Association. (2023). Standards of care in diabetes—2023. Diabetes Care, 46(1), 4–31.
Asadi, S., Gholami, M. S., Siassi, F., Qorbani, M., Khamoshian, K., & Sotoudeh, G. (2019). Curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial. Complementary Therapies in Medicine, 43, 253–260.
Balaji, R., Duraisamy, R., & Kumar, M. P. (2019). Complications of diabetes mellitus: A review. Drug Invention Today, 12(1).
Derosa, G., Maffioli, P., Simental-Mendía, L. E., Bo, S., & Sahebkar, A. (2016). Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research, 111, 394–404.
Ejaz, A., Wu, D., Kwan, P., & Meydani, M. (2009). Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. The Journal of Nutrition, 139(5), 919–925.
Funamoto, M., Shimizu, K., Sunagawa, Y., Katanasaka, Y., Miyazaki, Y., Kakeya, H., & Morimoto, T. (2019). Effects of highly absorbable curcumin in patients with impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Journal of Diabetes Research, 2019.
Ghorbani, Z., Hekmatdoost, A., & Mirmiran, P. (2014). Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle sesquiterpene curcuminoid constituents. International Journal of Endocrinology and Metabolism, 12(2), e17948.
Ghosh, S. S., Massey, H. D., Krieg, R., Fazelbhoy, Z. A., Ghosh, S., Sica, D. A., Fakhry, I., & Fried, L. F. (2014). Curcumin ameliorates renal failure in 5/6 nephrectomized rats: Role of inflammation. American Journal of Physiology-Renal Physiology, 306(5).
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: Lessons learned from clinical trials. The AAPS Journal, 15(1), 195–218.
Hodaei, H., Adibian, M., Nikpayam, O., Hedayati, M., & Sohrab, G. (2019). The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: A randomized, double-blind clinical trial. Diabetology & Metabolic Syndrome, 11, 1–8.
International Diabetes Federation. (2021). IDF diabetes atlas (10th ed.).
Jimenez-Osorio, A. S., Monroy, A., & Alavez, S. (2016). Curcumin and insulin resistance—Molecular targets and clinical evidences. BioFactors, 42(6), 561–580.
Karimian, M. S., Pirro, M., Majeed, M., & Sahebkar, A. (2017). Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine and Growth Factor Reviews, 33, 55–63.
Khajehdehi, P., Pakfetrat, M., Javidnia, K., Azad, F., Malekmakan, L., Nasab, M. H., & Dehghanzadeh, G. (2012). Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsed or refractory lupus nephritis: A randomized and placebo-controlled study. Journal of Renal Nutrition, 22(1), 50–57.
Machado, D. I., de Oliveira Silva, E., Ventura, S., & Vattimo, M. D. F. F. (2022). The effect of curcumin on renal ischemia/reperfusion injury in diabetic rats. Nutrients, 14(14), 2798.
Mirzaei, H., Shakeri, A., Rashidi, B., Jalili, A., Banikazemi, Z., & Sahebkar, A. (2017). Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomedicine & Pharmacotherapy, 85, 102–112.
Patel, S., & Santani, D. (2009). Role of NF-kB in the pathogenesis of diabetes and its associated complications. Pharmacological Reports, 61(4), 595–603.
Poolsup, N., Suksomboon, N., Kurnianta, P. D. M., & Deawjaroen, K. (2019). Effects of curcumin on glycemic control and lipid profile in prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis. PLoS ONE, 14(4).
Rahimi, H. R., Mohammadpour, A. H., Dastani, M., Jaafari, M. R., Abnous, K., Ghayour Mobarhan, M., & Kazemi Oskuee, R. (2016). The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: A randomized clinical trial. Avicenna Journal of Phytomedicine, 6(5), 567–577.
Son, Y., Lee, J. H., Cheong, Y. K., Chung, H. T., & Pae, H. O. (2013). Antidiabetic potential of the heme oxygenase-1 inducer curcumin analogues. BioMed Research International, 2013.
Srinivasan, S., Raman, R., Kulothungan, V., Swaminathan, G., & Sharma, T. (2017). Influence of serum lipids on the incidence and progression of diabetic retinopathy and macular oedema: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study‐II. Clinical and Experimental Ophthalmology, 45(9).
Su, L. Q., & Chi, H. Y. (2017). Effect of curcumin on glucose and lipid metabolism, FFAs and TNF-α in serum of type 2 diabetes mellitus rat models. Saudi Journal of Biological Sciences, 24(8), 1776–1780.
Suvarna, R., Shenoy, R. P., Hadapad, B. S., & Nayak, A. V. (2021). Effectiveness of polyherbal formulations for the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis. Journal of Ayurveda and Integrative Medicine, 12(1), 213–222.
Tomic, D., Shaw, J. E., & Magliano, D. J. (2022). The burden and risks of emerging complications of diabetes mellitus. Nature Reviews Endocrinology, 18(9), 525–539.
Vanaie, A., Shahidi, S., Iraj, B., Siadat, Z. D., Kabirzade, M., Shakiba, F., & Parvizian, H. (2019). Curcumin as a major active component of turmeric attenuates proteinuria in patients with overt diabetic nephropathy. Journal of Research in Medical Sciences, 24(1), 77.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Antigen : Jurnal Kesehatan Masyarakat dan Ilmu Gizi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
